Masaru Hiki Selected Research

Masaru Hiki Research Topics

Disease

25	Heart Failure 11/2023 - 01/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 06/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2019
4	Sleep Apnea Syndromes (Sleep Apnea) 10/2023 - 03/2017
3	Central Sleep Apnea (Central Sleep Apnea Syndrome) 02/2023 - 09/2017
3	Neoplasms (Cancer) 10/2020 - 08/2017
2	Frailty 11/2023 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2023 - 11/2017
2	Apnea 02/2023 - 08/2018
2	Body Weight (Weight, Body) 01/2023 - 10/2020
2	Critical Illness (Critically Ill) 03/2021 - 06/2017
2	Left Ventricular Dysfunction 02/2021 - 06/2020
2	Acute Coronary Syndrome 12/2019 - 11/2017
2	Obstructive Sleep Apnea 01/2018 - 09/2017
2	Thrombosis (Thrombus) 11/2017 - 01/2017
2	Inflammation (Inflammations) 10/2017 - 06/2017
1	Aneurysm (Aneurysms) 03/2024
1	Hyperuricemia 10/2023
1	Right Ventricular Dysfunction 09/2023
1	Diabetes Mellitus 01/2023
1	Atrial Fibrillation 01/2023
1	Anemia 01/2023
1	Sarcopenia 01/2023
1	Hypoalbuminemia 06/2019
1	Delirium 11/2018
1	Hyponatremia 09/2018
1	Sleepiness 08/2018
1	Chronic Renal Insufficiency 11/2017
1	Coronary Stenosis (Coronary Artery Stenosis) 11/2017
1	Hyperglycemia 11/2017
1	Venous Thromboembolism 10/2017
1	Thrombophilia 10/2017
1	Ventricular Tachycardia 09/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2017
1	Connective Tissue Diseases (Connective Tissue Disease) 08/2017
1	Malnutrition (Nutritional Deficiencies) 06/2017
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2017
1	Ventricular Fibrillation 07/2013

Drug/Important Bio-Agent (IBA)

6	Hemoglobins (Hemoglobin)IBA 02/2023 - 03/2017
4	SodiumIBA 01/2023 - 11/2017
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2017 - 08/2017
3	Uric Acid (Urate)IBA 10/2023 - 01/2023
3	CreatinineIBA 02/2023 - 08/2018
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 02/2023
2	Xanthine DehydrogenaseIBA 10/2023 - 10/2023
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2023 - 01/2018
2	CholesterolIBA 02/2023 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 02/2023 - 10/2020
2	Urea (Carbamide)FDA LinkGeneric 01/2023 - 08/2018
2	NitrogenIBA 01/2023 - 08/2018
2	coenzyme Q10 (CoQ10)IBA 03/2021 - 06/2017
2	astaxanthine (astaxanthin)IBA 02/2021 - 06/2020
2	Docosahexaenoic AcidsIBA 09/2017 - 08/2017
2	Eicosapentaenoic AcidIBA 09/2017 - 08/2017
2	8,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)IBA 08/2017 - 08/2017
1	GadoliniumIBA 03/2024
1	HypoxanthineIBA 10/2023
1	XanthineIBA 10/2023
1	Hyaluronic Acid (Hyaluronan)IBA 09/2023
1	LDL CholesterolIBA 02/2023
1	AlbuminsIBA 02/2023
1	HDL LipoproteinsIBA 01/2023
1	Cystatin CIBA 01/2023
1	Fatty Acid-Binding ProteinsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Carbon DioxideIBA 06/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	alpha-1-microglobulinIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	C-Reactive ProteinIBA 12/2019
1	Serum AlbuminIBA 06/2019
1	CatecholaminesIBA 08/2018
1	SteroidsIBA 11/2017
1	1,5-anhydroglucitolIBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	SymportersIBA 11/2017
1	Arachidonic Acid (Vitamin F)IBA 08/2017
1	Tolvaptan FDA Link 05/2017
1	DiureticsIBA 05/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2013

Therapy/Procedure

5	Patient Readmission 01/2023 - 03/2020
5	Therapeutics 08/2018 - 05/2017
2	Percutaneous Coronary Intervention 01/2019 - 08/2018
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2017 - 07/2013
1	Length of Stay 04/2020
1	Critical Care (Surgical Intensive Care) 11/2018
1	Stents 11/2017
1	Glycemic Control 11/2017
1	Gastrectomy 11/2017
1	Continuous Positive Airway Pressure 09/2017
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2017
1	Thrombolytic Therapy 01/2017
1	Defibrillators (Defibrillator) 07/2013